Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker BVS · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Observational, Non-interventional Use of LIPUS to Mitigate Fracture Non-union in Patients at Risk NCT03382483 · Mitigation of Fracture Non-union in Patients at Risk Low intensity pulsed ultrasound | BVS Bioventus LLC | — | Completed | 12,387 | May 26, 2020 | Registry ↗ |
| Jun 26, 2024 | Study of StimRouter for Chronic Knee OA Pain NCT05644639 · Osteoarthritis, Knee StimRouter Neuromodulation System | BVS Bioventus LLC | — | Completed | 13 | Oct 1, 2023 | Registry ↗ |
| Aug 28, 2023 | OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study NCT05405374 · Lumbar Spine Disease, Lumbar Spondylolisthesis OSTEOAMP, Infuse | BVS Bioventus LLC | Not applicable | Unknown | 101 | Oct 2024 | Registry ↗ |
| Jul 19, 2022 | Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis NCT05100225 · Osteoarthritis, Knee PTP-001, Placebo control | BVS Bioventus LLC | Phase 2 | Active, not recruiting | 210 | Oct 31, 2022 | Registry ↗ |
| Dec 22, 2021 | Safety Study of PTP-001 for Treating Knee Osteoarthritis NCT04632966 · Knee Osteoarthritis Biological: PTP-001 | BVS Bioventus LLC | Phase 1 | Unknown | 20 | Sep 2022 | Registry ↗ |
| Apr 27, 2021 | SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder NCT00479687 · Osteoarthritis of the Shoulder SUPARTZ®, Phosphate Buffered Saline | BVS Bioventus LLC | Not applicable | Completed | 300 | Oct 2009 | Registry ↗ |
| Apr 9, 2021 | Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoart… NCT01295580 · Knee Osteoarthritis ARTZ, DUROLANE | BVS Bioventus LLC | Not applicable | Completed | 349 | Aug 2011 | Registry ↗ |
| Apr 2, 2021 | Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery NCT00744861 · Lumbar Degenerative Disc Disease Exospine sham, Exospine | BVS Bioventus LLC | Not applicable | Terminated | 328 | May 2012 | Registry ↗ |
| Mar 9, 2021 | Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa®… NCT02110238 · Osteoarthritis Supartz, Euflexxa | BVS Bioventus LLC | Not applicable | Completed | 421 | Nov 2014 | Registry ↗ |
| Feb 16, 2021 | Prospective Single Center Open Label Study of Shoulder OA Pain NCT02610504 · Osteoarthritis Durolane | BVS Bioventus LLC | Not applicable | Completed | 41 | May 23, 2017 | Registry ↗ |
| Nov 5, 2020 | A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP® NCT02225444 · Spondylolisthesis, Scoliosis OsteoAMP | BVS Bioventus LLC | — | Completed | 42 | Jun 24, 2019 | Registry ↗ |
| Sep 21, 2016 | 26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthri… NCT02627859 · Osteoarthritis Durolane SJ | BVS Bioventus LLC | Phase 4 | Unknown | 37 | Aug 2016 | Registry ↗ |
| Feb 12, 2016 | Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee NCT01543737 · Knee Osteoarthritis 3ml hyaluronic acid (DUROLANE), 2ml hyaluronic acid, (HYALG… | BVS Bioventus LLC | Not applicable | Terminated | 290 | Feb 2014 | Registry ↗ |
| Dec 8, 2015 | Trial to Evaluate UltraSound in the Treatment of Tibial Fractures NCT00667849 · Tibial Fractures Exogen 4000+, Sham | BVS Bioventus LLC | Not applicable | Terminated | 501 | Dec 2012 | Registry ↗ |
14 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:10 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances